Published in Biomed Res Int on May 14, 2015
The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99
A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med (1989) 10.98
The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat Rev Microbiol (2009) 8.13
Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection. Proc Natl Acad Sci U S A (1992) 7.74
The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med (1995) 6.17
Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control. Immunity (2008) 5.86
Immunity to tuberculosis. Annu Rev Immunol (2004) 5.60
The sympathetic nerve--an integrative interface between two supersystems: the brain and the immune system. Pharmacol Rev (2000) 5.40
Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol (2012) 4.44
M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) (2004) 4.38
HIV infection-associated tuberculosis: the epidemiology and the response. Clin Infect Dis (2010) 4.19
Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection. J Immunol (1993) 3.51
Dissemination of Mycobacterium tuberculosis is influenced by host factors and precedes the initiation of T-cell immunity. Infect Immun (2002) 3.50
Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med (1995) 3.29
Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control. PLoS Pathog (2010) 2.99
Glucocorticoids in T cell development and function*. Annu Rev Immunol (2000) 2.63
Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis (2010) 2.60
Randomized trial of adjunctive interleukin-2 in adults with pulmonary tuberculosis. Am J Respir Crit Care Med (2003) 2.59
Pathogenic mechanisms of HIV disease. Annu Rev Pathol (2011) 2.36
Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis. Eur J Immunol (1995) 2.34
The immunological life cycle of tuberculosis. Nat Rev Immunol (2012) 2.25
Anti-TNF immunotherapy reduces CD8+ T cell-mediated antimicrobial activity against Mycobacterium tuberculosis in humans. J Clin Invest (2009) 2.12
Phenotypic and functional analysis of CD4+ CD25- Foxp3+ T cells in patients with systemic lupus erythematosus. J Immunol (2009) 1.71
Endocrine and cytokine responses in humans with pulmonary tuberculosis. Brain Behav Immun (2006) 1.68
A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis. AIDS (2004) 1.65
Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol (2005) 1.63
Increase in gamma interferon-secreting CD8(+), as well as CD4(+), T cells in lungs following aerosol infection with Mycobacterium tuberculosis. Infect Immun (1999) 1.49
The immunological aspects of latency in tuberculosis. Clin Immunol (2004) 1.48
Th17 and regulatory T cells: implications for AIDS pathogenesis. Curr Opin HIV AIDS (2010) 1.45
The immunology of tuberculosis: from bench to bedside. Respirology (2010) 1.29
The five Rs of glucocorticoid action during inflammation: ready, reinforce, repress, resolve, and restore. Trends Endocrinol Metab (2013) 1.21
Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells? Arthritis Res Ther (2009) 1.19
Th17/Treg imbalance in adult patients with minimal change nephrotic syndrome. Clin Immunol (2011) 1.12
Neural-immune interactions in health and disease. Ann N Y Acad Sci (2002) 1.09
Glucocorticoid and mineralocorticoid resistance/hypersensitivity syndromes. J Endocrinol (2001) 1.09
Serum cortisol and DHEA concentrations during HIV infection. Psychoneuroendocrinology (1997) 1.06
16alpha-Bromoepiandrosterone restores T helper cell type 1 activity and accelerates chemotherapy-induced bacterial clearance in a model of progressive pulmonary tuberculosis. J Infect Dis (2004) 1.05
Identity of mysterious CD4+CD25-Foxp3+ cells in SLE. Arthritis Res Ther (2010) 1.03
T cell exhaustion during persistent viral infections. Virology (2015) 1.00
Endogenous glucocorticoids cause thymus atrophy but are protective during acute Trypanosoma cruzi infection. J Endocrinol (2006) 0.99
Dehydroepiandrosterone antagonizes the suppressive effects of dexamethasone on lymphocyte proliferation. Endocrinology (1991) 0.99
Conversion of dehydroepiandrosterone to downstream steroid hormones in macrophages. J Endocrinol (2000) 0.96
In vitro potentiation of lymphocyte activation by dehydroepiandrosterone, androstenediol, and androstenetriol. J Immunol (1994) 0.94
Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines. Cytokine Growth Factor Rev (2012) 0.93
Hypothalamic-pituitary-adrenal axis in HIV infection and disease. Endocrinol Metab Clin North Am (2014) 0.91
Androstenediol and dehydroepiandrosterone protect mice against lethal bacterial infections and lipopolysaccharide toxicity. J Med Microbiol (1999) 0.91
A possible role for the cortisol/anticortisols imbalance in the progression of human immunodeficiency virus. Psychoneuroendocrinology (1997) 0.90
Type 1 and type 2 cytokines in HIV infection -- a possible role in apoptosis and disease progression. Ann Med (1997) 0.90
Adjuvant interferon gamma in patients with drug - resistant pulmonary tuberculosis: a pilot study. BMC Infect Dis (2004) 0.89
Improvement in immune parameters and human immunodeficiency virus-1 viral response in individuals treated with 16alpha-bromoepiandrosterone (HE2000). Clin Microbiol Infect (2006) 0.88
Reduction of parasite levels in patients with uncomplicated malaria by treatment with HE2000. Am J Trop Med Hyg (2007) 0.87
Oxidative metabolism of dehydroepiandrosterone (DHEA) and biologically active oxygenated metabolites of DHEA and epiandrosterone (EpiA)--recent reports. Steroids (2011) 0.85
Contact investigation in households of patients with tuberculosis in Hanoi, Vietnam: a prospective cohort study. PLoS One (2012) 0.85
The impact of infectious diseases upon neuroendocrine circuits. Neuroimmunomodulation (2009) 0.84
Safety and activity of the immune modulator HE2000 on the incidence of tuberculosis and other opportunistic infections in AIDS patients. Antimicrob Agents Chemother (2007) 0.84
Human immunodeficiency virus type-1 accessory protein Vpr: a causative agent of the AIDS-related insulin resistance/lipodystrophy syndrome? Ann N Y Acad Sci (2004) 0.83
Asthma and dehydroepiandrosterone (DHEA): facts and hypotheses. Inflammation (2010) 0.82
Alterations in the pituitary-adrenal axis of adult mice following neonatal exposure to interleukin-1. Brain Behav Immun (1996) 0.82
Adrenal function in the human immunodeficiency virus-infected patient. Arch Intern Med (2002) 0.82
Androstenetriol and androstenediol. Protection against lethal radiation and restoration of immunity after radiation injury. Ann N Y Acad Sci (2000) 0.81
The relationship of serum DHEA-S and cortisol levels to measures of immune function in human immunodeficiency virus-related illness. Am J Med Sci (1993) 0.81
Hypothalamic-pituitary-adrenal function in non-AIDS patients with advanced HIV infection. Am J Med Sci (1993) 0.80
Low dose (1 microg) adrenocorticotropin stimulation test in the evaluation of hypothalamo-pituitary-adrenal axis in patients with active pulmonary tuberculosis. J Endocrinol Invest (2000) 0.80
A hormonal and radiological evaluation of adrenal gland in patients with acute or chronic pulmonary tuberculosis. Clin Endocrinol (Oxf) (1994) 0.80
Modulation of the phenotype and function of Mycobacterium tuberculosis-stimulated dendritic cells by adrenal steroids. Int Immunol (2013) 0.79
Stimulating effect of HIV-1 coat protein gp120 on corticotropin-releasing hormone and arginine vasopressin in the rat hypothalamus: involvement of nitric oxide. Exp Neurol (2000) 0.79
Dynamics of adrenal steroids are related to variations in Th1 and Treg populations during Mycobacterium tuberculosis infection in HIV positive persons. PLoS One (2012) 0.78
The adrenal steroid response during tuberculosis and its effects on the mycobacterial-driven IFN-gamma production of patients and their household contacts. Ann N Y Acad Sci (2009) 0.77
TGF-β neutralization abrogates the inhibited DHEA production mediated by factors released from M. tuberculosis-stimulated PBMC. Ann N Y Acad Sci (2012) 0.77
Differential effect of DHEA on mitogen-induced proliferation of T and B lymphocytes. J Steroid Biochem Mol Biol (2006) 0.77
Glucocorticoid resistance and the immune function in the immunodeficiency syndrome. Ann N Y Acad Sci (1998) 0.77
Adverse neuro-immune-endocrine interactions in patients with active tuberculosis. Mol Cell Neurosci (2012) 0.76
Adrenocortical function in patients investigated for active tuberculosis. Chest (1992) 0.76
Immunomodulatory effects of zinc and DHEA on the Th-1 immune response in rats infected with Trypanosoma cruzi. Immunobiology (2009) 0.76
Adrenal function during tuberculous infection and effects of antituberculosis treatment on endogenous and exogenous steroids. Int J Tuberc Lung Dis (1998) 0.75